Quentin McCubbin - Jan 26, 2023 Form 4 Insider Report for Frequency Therapeutics, Inc. (FREQ)

Role
Chief Manufacturing Officer
Signature
/s/ James P. Abely, Attorney-in-Fact for Quentin McCubbin
Stock symbol
FREQ
Transactions as of
Jan 26, 2023
Transactions value $
$0
Form type
4
Date filed
1/27/2023, 03:38 PM
Previous filing
Aug 19, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FREQ Restricted Stock Unit Award $0 +105K $0.00 105K Jan 26, 2023 Common Stock 105K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2 The restricted stock units will vest in four equal annual installments beginning on January 26, 2024.